Prevalence of an abnormal ankle-brachial index in patients with antiphospholipid syndrome with pregnancy loss but without thrombosis: A controlled study [2]

Annals of the Rheumatic Diseases

Volumn 65, Issue 5, 2006, Pages 683-684

  Christodoulou, C ^a   Zain, M ^a   Bertolaccini, M L ^a   Sangle, S ^a   Khamashta, M A ^a   Hughes, G R V ^a   D'Cruz, D P ^a  

^a ST THOMAS HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

PHOSPHOLIPID ANTIBODY;

ADULT; ANKLE BRACHIAL INDEX; ANTIPHOSPHOLIPID SYNDROME; CARDIOVASCULAR RISK; CLINICAL ARTICLE; CONTROLLED STUDY; DIABETES MELLITUS; FEMALE; HUMAN; HYPERCHOLESTEROLEMIA; HYPERTENSION; KIDNEY FAILURE; LETTER; PREGNANCY DISORDER; PREVALENCE; PRIORITY JOURNAL; SMOKING; SYSTEMIC LUPUS ERYTHEMATOSUS; THROMBOSIS;

ABORTION, SPONTANEOUS; ADOLESCENT; ADULT; ANKLE; ANTIPHOSPHOLIPID SYNDROME; BRACHIAL ARTERY; CASE-CONTROL STUDIES; FEMALE; HUMANS; MIDDLE AGED; OBSERVER VARIATION; PREGNANCY; REGIONAL BLOOD FLOW;

EID: 33646263595     PISSN: 00034967     EISSN: None     Source Type: Journal    
DOI: 10.1136/ard.2005.037911     Document Type: Letter

References (10)

1. Wilson WA, Gharavi AE, Koike T, Lockshin MD, Branch DW, Piette JC, et al. International consensus statement on preliminary classification criteria for definite antiphospholipid syndrome: report of an international workshop. Arthritis Rheum 1999;42:1309-11.
2. Greenland P, Abrams J, Aurigemma GP, Bond MG, Clark LC, Criqui MH, et al. Prevention conference V: beyond secondary prevention: identifying the high-risk patient for primary prevention: non-invasive tests of atherosclerotic burden: Writing group III. Circulation 2000;101:e16-22.
3. Sacks D, Bakal CW, Beatty PT, Becker GJ, Cardella JF, Raabe RD, et al. Position statement on the use of the ankle-brachial index in the evaluation of patients with peripheral vascular disease. A consensus statement developed by the standards division of the Society of Cardiovascular and International Radiology. J Vasc Interv Radiol 2002;13:353.
4. Baron MA, Khamashta MA, Hughes GRV, D'Cruz DP. Prevalence of an abnormal ankle-brachial index in patients with primary antiphospholipid syndrome: preliminary data. Ann Rheum Dis 2005;64:144-6.
5. Theodoridou A, Bento L, D'Cruz DP, Khamashta MA, Hughes GRV. Prevalence and associations of an abnormal ankle-brachial index in systemic lupus erythematosus: a pilot study. Ann Rheum Dis 2003;62:1199-203.
6. Urowitz MB, Bookman AM, Koehler BE, Gordon DA, Smythe HA, Ogryzlo MA. The bimodal mortality pattern of SLE. Am J Med 1976;60:221-5.
7. Doherty NE, Siegel RJ. Cardiovascular manifestations of systemic lupus erythematosus. Am Heart J 1985;110:1257-65.
8. Vaarala O. Antiphospholipid antibodies and atherosclerosis. Lupus 1996;5:442-7.
9. Matsuura E, Koike T. Accelerated atheroma and anti-β2-glycoprotein I antibodies. Lupus 2000;9:210-16.
10. Petri M. Detection of coronary artery disease and the role of traditional risk factors in the Hopkins Lupus Cohort. Lupus 2000;9:170-5.